Use of TrachPhone in Tracheostomized Patients

NCT ID: NCT06487104

Last Updated: 2025-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-05

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The use of Heat and Moisture Exchangers (HMEs) and their positive impact on pulmonary health have been extensively studied in patients with head and neck cancer but have not been systematically explored in other patient populations breathing through a neck stoma.

The objective of this clinical investigation is to compare the use of HMEs to the use of External Humidifiers (EHs) on pulmonary secretion management, their usability and safety, for humidifying inhaled air in patients that received a tracheostomy due to a neurological condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tracheostomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Single-center, two-armed randomized controlled trial with a subsequent feasibility phase, transitioning control-group patients to investigational device arm
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1 - HME

24/7 use of TrachPhone HME for the entirety of study

Group Type EXPERIMENTAL

TrachPhone HME

Intervention Type DEVICE

Use of TrachPhone HME for humidification of inhaled air in tracheostomized patients.

The TrachPhone HME is an HME specifically designed for tracheostomy patients.

Arm 2 - EH

24/7 use of EH until first follow-up (T1), then 24/7 use of TrachPhone HME for the remainder of the study participation.

Group Type ACTIVE_COMPARATOR

TrachPhone HME

Intervention Type DEVICE

Use of TrachPhone HME for humidification of inhaled air in tracheostomized patients.

The TrachPhone HME is an HME specifically designed for tracheostomy patients.

External Humidifier (Usual Care)

Intervention Type DEVICE

Usual care routines using an External Humidifier for humidification of inhaled air in tracheostomized patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TrachPhone HME

Use of TrachPhone HME for humidification of inhaled air in tracheostomized patients.

The TrachPhone HME is an HME specifically designed for tracheostomy patients.

Intervention Type DEVICE

External Humidifier (Usual Care)

Usual care routines using an External Humidifier for humidification of inhaled air in tracheostomized patients.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Tracheostomy patient outside critical care
* Self-ventilating via a tracheostomy tube, independent of cuff status
* 18 years or older

Exclusion Criteria

* Patients with tidal volume beyond recommended range (50-1000 ml)
* Dehydration
* Very heavy/excessive secretion from the lungs and airways (requiring more frequently tracheal suction, more than hourly suctioning)
* High oxygen need (FiO2 \> 0.4)
* Acutely deteriorating patient
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Barts & The London NHS Trust

OTHER

Sponsor Role collaborator

Atos Medical AB

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amanda Thomas, Dr

Role: PRINCIPAL_INVESTIGATOR

The Royal London Hospital, Barts Health NHS Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Royal London Hospital, Barts Health NHS Trust

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TrachPhone

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.